Derek Dang

Derek Dang

Auto-generated profile, based on publicly available information

Derek Dang

10Department of Pathology, University of Michigan, Ann Arbor, Michigan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PPPooja Panwalkar
Pooja Panwalkar
BTBenita Tamrazi
Benita Tamrazi
DDDerek Dang
Derek Dang
CCChan Chung
Chan Chung
SSStefan Sweha
Stefan Sweha
SVSriram Venneti
Sriram Venneti
Childhood posterior fossa group A ependymomas demonstrate integrated metabolic and epigenetic pathways that can be disrupted by metformin.

2 May 2023 in Cancer Research
Verified
Journal Article
Closed access
PDF file
DMDipika R. Mohan
Dipika R. Mohan
KBKleiton S. Borges
Kleiton S. Borges
IFIsabella Finco
Isabella Finco
CLChristopher R. LaPensee
Christopher R. LaPensee
JRJuilee Rege
Juilee Rege
GHGary D. Hammer
Gary D. Hammer
Adrenocortical carcinoma (ACC) is a rare cancer in which tissue-specific differentiation is paradoxically associated with dismal outcomes. The differentiated ACC subtype CIMP-high is prevalent, incurable, and routinely fatal. CIMP-high ACC possess abnormal DNA methylation and frequent β-catenin–activating mutations. Here, we demonstrated that ACC differentiation is maintained by a balance between nuclear, tissue-specific β-catenin–containing complexes, and the epigenome. On chromatin, β-catenin bound master adrenal transcription factor SF1 and hijacked the adrenocortical super-enhancer landscape to maintain differentiation in CIMP-high ACC; off chromatin, β-catenin bound histone methyltransferase EZH2. SF1/β-catenin and EZH2/β-catenin complexes present in normal adrenals persisted through all phases of ACC evolution. Pharmacologic EZH2 inhibition in CIMP-high ACC expelled SF1/β-catenin from chromatin and favored EZH2/β-catenin assembly, erasing differentiation and restraining cancer growth in vitro and in vivo. These studies illustrate how tissue-specific programs shape oncogene selection, surreptitiously encoding targetable therapeutic vulnerabilities. Significance: Oncogenic β-catenin can use tissue-specific partners to regulate cellular differentiation programs that can be reversed by epigenetic therapies, identifying epigenetic control of differentiation as a viable target for β-catenin–driven cancers.

16 September 2024
Verified
Other
Open access
DMDipika R. Mohan
Dipika R. Mohan
KBKleiton S. Borges
Kleiton S. Borges
IFIsabella Finco
Isabella Finco
CLChristopher R. LaPensee
Christopher R. LaPensee
JRJuilee Rege
Juilee Rege
GHGary D. Hammer
Gary D. Hammer
Supplementary Table 1: NCI-H295R RNA-seq FPKM table, Related to Figures 2-4, 6.

16 September 2024
Verified
Other
Open access
DMDipika R. Mohan
Dipika R. Mohan
KBKleiton S. Borges
Kleiton S. Borges
IFIsabella Finco
Isabella Finco
CLChristopher R. LaPensee
Christopher R. LaPensee
JRJuilee Rege
Juilee Rege
GHGary D. Hammer
Gary D. Hammer
Supplementary Table 1: NCI-H295R RNA-seq FPKM table, Related to Figures 2-4, 6.

23 June 2023
Verified
Other
Open access
DMDipika R. Mohan
Dipika R. Mohan
KBKleiton S. Borges
Kleiton S. Borges
IFIsabella Finco
Isabella Finco
CLChristopher R. LaPensee
Christopher R. LaPensee
JRJuilee Rege
Juilee Rege
GHGary D. Hammer
Gary D. Hammer
Supplementary Table 1: NCI-H295R RNA-seq FPKM table, Related to Figures 2-4, 6.

5 July 2023
Verified
Other
Open access
DMDipika R. Mohan
Dipika R. Mohan
KBKleiton S. Borges
Kleiton S. Borges
IFIsabella Finco
Isabella Finco
CLChristopher R. LaPensee
Christopher R. LaPensee
JRJuilee Rege
Juilee Rege
GHGary D. Hammer
Gary D. Hammer
Supplementary Table 1: NCI-H295R RNA-seq FPKM table, Related to Figures 2-4, 6.